Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis

被引:40
作者
Hao, Dongsheng [1 ,2 ]
Li, Ming [1 ,2 ]
Wu, Zhihong [1 ,2 ]
Duan, Yuanhui [1 ,2 ]
Li, Deling [1 ,2 ]
Qiu, Guixing [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
关键词
Adiponectin; Osteoarthritis; Synovial fluid; Biomarker; Aggrecan; BODY-WEIGHT; CARTILAGE; OBESITY; KNEE; ARTHRITIS; COMPLEX; SERUM; HAND; HIP;
D O I
10.1007/s00296-010-1516-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to investigate adiponectin levels in both plasma and synovial fluid of female patients with knee osteoarthritis (OA) and to analyze the correlation between adiponectin and degradation markers of cartilage matrix in synovial fluid. Thirty female patients with knee OA were enrolled in this study. Levels of adiponectin and degradation markers of cartilage matrix were measured using enzyme-linked immunosorbent assay. Adiponectin level in synovial fluid was significantly lower with respect to paired plasma level (0.93 +/- 0.64 vs. 7.50 +/- 3.29 mu g/ml, P < 0.001). Correlation analysis showed that synovial fluid adiponectin significantly correlated with degradation markers of aggrecan, AGG1 (r = 0.441, P = 0.015) and AGG2 (r = 0.445, P = 0.014), but not significantly correlated with degradation marker of collagen II, CTX-II. These findings suggest that adiponectin might involve in the regulation of the degradation of cartilage matrix in OA.
引用
收藏
页码:1433 / 1437
页数:5
相关论文
共 24 条
[1]   DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[2]   Aggrecanase-mediated cartilage degradation [J].
Arner, EC .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (03) :322-329
[3]   Evidence for a protective role for adiponectin in osteoarthritis [J].
Chen, Tsu-Hsin ;
Chen, Linda ;
Hsieh, Ming-Shium ;
Chang, Chih-Peng ;
Chou, Der-Tsay ;
Tsai, Shu-Huei .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (08) :711-718
[4]  
Cicuttini FM, 1996, J RHEUMATOL, V23, P1221
[5]   The potential of adiponectin in driving arthritis [J].
Ehling, Angela ;
Schaeffler, Andreas ;
Herfarth, Hans ;
Tarner, Ingo H. ;
Anders, Sven ;
Distler, Oliver ;
Paul, Gisela ;
Distler, Joerg ;
Gay, Steffen ;
Schoelmerich, Jurgen ;
Neumann, Elena ;
Mueller-Ladner, Ulf .
JOURNAL OF IMMUNOLOGY, 2006, 176 (07) :4468-4478
[6]  
FOSANG AJ, 1992, J BIOL CHEM, V267, P19470
[7]   GUIDELINES FOR THE MEDICAL-MANAGEMENT OF OSTEOARTHRITIS .1. OSTEOARTHRITIS OF THE HIP [J].
HOCHBERG, MC ;
ALTMAN, RD ;
BRANDT, KD ;
CLARK, BM ;
DIEPPE, PA ;
GRIFFIN, MR ;
MOSKOWITZ, RW ;
SCHNITZER, TJ .
ARTHRITIS AND RHEUMATISM, 1995, 38 (11) :1535-1540
[8]   T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin [J].
Hug, C ;
Wang, J ;
Ahmad, NS ;
Bogan, JS ;
Tsao, TS ;
Lodish, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10308-10313
[9]   Adipose tissue as an endocrine organ [J].
Kershaw, EE ;
Flier, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2548-2556
[10]   Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin [J].
Kobayashi, H ;
Ouchi, N ;
Kihara, S ;
Walsh, K ;
Kumada, M ;
Abe, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION RESEARCH, 2004, 94 (04) :E27-E31